comparemela.com
Home
Live Updates
Idorsia Pharmaceuticals Ltd: Idorsia announces financial results for the first quarter 2022 - first product launched, second in the starting blocks : comparemela.com
Idorsia Pharmaceuticals Ltd: Idorsia announces financial results for the first quarter 2022 - first product launched, second in the starting blocks
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - April 26, 2022 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first quarter of 2022. Business highlights PIVLAZ
Related Keywords
Japan
,
United States
,
Canada
,
Mochida
,
Miyazaki
,
Allschwil
,
Switzerland General
,
Switzerland
,
America
,
Japanese
,
Swiss
,
Andrewc Weiss
,
Neurocrine Biosciences
,
Satoshi Tanaka
,
Jennifer Aniston
,
Jean Paul Clozel
,
Simon Jose
,
Head Of Investor Relations Corporate Communications
,
Janssen Biotech Inc
,
Committee For Medicinal Products Human Use
,
Clinical Development
,
Neurocrine Biosciences Inc
,
Idorsia Ltd
,
European Commission
,
Day Center
,
Swiss Exchange
,
Syneos Health
,
Alliance For
,
Mochida Pharmaceutical Co Ltd
,
Idorsia Pharmaceuticals Ltd
,
European Medicines Agency
,
Us Drug Enforcement Administration
,
Paul Clozel
,
Chief Executive Officer
,
Janssen Biotech
,
Chief Financial Officer
,
Patty Torr
,
Wake Up America
,
Enforcement Administration
,
Controlled Substance Act
,
Full Prescribing Information
,
Medication Guide
,
Idorsia Japan
,
Chief Commercial Officer
,
Medicinal Products
,
Human Use
,
Results Day Center
,
Vice President
,
Investor Relations
,
Pharmaceuticals Ltd
,
Idorsia
,
Pharmaceuticals
,
Nnounces
,
Financial
,
Results
,
First
,
Quarter
,
022
,
Product
,
Aunched
,
Second
,
Starting
,
Blocks
,
comparemela.com © 2020. All Rights Reserved.